Article Text

PDF
Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA
  1. George D Azevedo1,
  2. Rafael G N Gadelha2,
  3. Maria José Vilar3
  1. 1
    Department of Morphology, Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal-RN, Brazil
  2. 2
    Department of Clinical Medicine, Federal University of Rio Grande do Norte, Natal-RN, Brazil
  3. 3
    Division of Rheumatology, Department of Clinical Medicine, Postgraduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal-RN, Brazil
  1. George D Azevedo, Departamento de Morfologia do Centro de Biociências, Campus Universitário, UFRN, BR 101, Lagoa Nova Natal-RN, 59067-010, Brazil; georgedantas{at}uol.com.br

Statistics from Altmetric.com

We read with great interest the recent article by Chung et al on the high prevalence of metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE).1 This topic is extremely relevant as regards the current clinical management of patients with SLE, since findings from several studies point to increased cardiovascular risk associated with this disease.24 As with most previous research on the incidence of MetS, this study was conducted in the American population where the prevalence of obesity is higher than in other countries.1 However, it is very important to consider the results from studies conducted in different populations when analysing the influence of obesity and other …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.